RSLS Annual Accounts Receivable
$2.46 M
-$127.00 K-4.90%
31 December 2023
Summary:
As of January 22, 2025, RSLS annual accounts receivable is $2.46 million, with the most recent change of -$127.00 thousand (-4.90%) on December 31, 2023. During the last 3 years, it has fallen by -$1.13 million (-31.35%). RSLS annual accounts receivable is now -48.74% below its all-time high of $4.80 million, reached on December 31, 2019.RSLS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Quarterly Accounts Receivable
$2.21 M
+$192.00 K+9.51%
30 September 2024
Summary:
As of January 22, 2025, RSLS quarterly accounts receivable is $2.21 million, with the most recent change of +$192.00 thousand (+9.51%) on September 30, 2024. Over the past year, it has dropped by -$802.00 thousand (-26.63%). RSLS quarterly accounts receivable is now -55.91% below its all-time high of $5.01 million, reached on June 30, 2019.RSLS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.9% | -26.6% |
| 3 y3 years | -31.4% | -43.8% |
| 5 y5 years | +113.6% | -42.5% |
RSLS Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.2% | at low | -44.6% | +9.5% |
| 5 y | 5-year | -48.7% | at low | -54.0% | +9.5% |
| alltime | all time | -48.7% | -55.9% |
ReShape Lifesciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.21 M(+9.5%) |
| June 2024 | - | $2.02 M(-0.3%) |
| Mar 2024 | - | $2.02 M(-17.8%) |
| Dec 2023 | $2.46 M(-4.9%) | $2.46 M(-18.2%) |
| Sept 2023 | - | $3.01 M(+19.1%) |
| June 2023 | - | $2.53 M(-1.5%) |
| Mar 2023 | - | $2.57 M(-0.8%) |
| Dec 2022 | $2.59 M(-35.0%) | $2.59 M(-18.5%) |
| Sept 2022 | - | $3.18 M(-6.1%) |
| June 2022 | - | $3.38 M(-3.3%) |
| Mar 2022 | - | $3.50 M(-12.3%) |
| Dec 2021 | $3.99 M(+11.1%) | $3.99 M(+1.3%) |
| Sept 2021 | - | $3.93 M(-11.8%) |
| June 2021 | - | $4.46 M(+17.0%) |
| Mar 2021 | - | $3.81 M(+6.3%) |
| Dec 2020 | $3.59 M(-25.3%) | $3.59 M(-6.7%) |
| Sept 2020 | - | $3.84 M(+1.8%) |
| June 2020 | - | $3.78 M(-4.5%) |
| Mar 2020 | - | $3.96 M(-17.6%) |
| Dec 2019 | $4.80 M(+316.7%) | $4.80 M(+36.2%) |
| Sept 2019 | - | $3.53 M(-29.6%) |
| June 2019 | - | $5.01 M(+2051.1%) |
| Mar 2019 | - | $233.00 K(-79.8%) |
| Dec 2018 | $1.15 M(+78.9%) | $1.15 M(+116.7%) |
| Sept 2018 | - | $532.10 K(+19.3%) |
| June 2018 | - | $446.00 K(-53.7%) |
| Mar 2018 | - | $962.40 K(+49.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $644.50 K(+348.5%) | $644.50 K(+93.5%) |
| Sept 2017 | - | $333.10 K(+204.5%) |
| June 2017 | - | $109.40 K(+60.4%) |
| Mar 2017 | - | $68.20 K(-52.5%) |
| Dec 2016 | $143.70 K(+148.2%) | $143.70 K(-25.0%) |
| Sept 2016 | - | $191.70 K(+5.0%) |
| June 2016 | - | $182.50 K(+231.8%) |
| Mar 2016 | - | $55.00 K(-5.0%) |
| Dec 2015 | $57.90 K(+1967.9%) | $57.90 K(+130.7%) |
| Sept 2015 | - | $25.10 K(-77.7%) |
| June 2015 | - | $112.50 K(+7400.0%) |
| Mar 2015 | - | $1500.00(-46.4%) |
| Dec 2014 | $2800.00(-84.2%) | $2800.00(>+9900.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $17.70 K(-66.2%) | $17.70 K(-66.8%) |
| Sept 2013 | - | $53.30 K(+213.5%) |
| June 2013 | - | $17.00 K(-8.6%) |
| Mar 2013 | - | $18.60 K(-64.5%) |
| Dec 2012 | $52.40 K(>+9900.0%) | $52.40 K(-0.4%) |
| Sept 2012 | - | $52.60 K(+211.2%) |
| June 2012 | - | $16.90 K(-86.3%) |
| Mar 2012 | - | $123.10 K(>+9900.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2009 | - | $19.90 K(+3.1%) |
| Dec 2008 | $19.30 K | $19.30 K |
FAQ
- What is ReShape Lifesciences annual accounts receivable?
- What is the all time high annual accounts receivable for ReShape Lifesciences?
- What is ReShape Lifesciences annual accounts receivable year-on-year change?
- What is ReShape Lifesciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly accounts receivable year-on-year change?
What is ReShape Lifesciences annual accounts receivable?
The current annual accounts receivable of RSLS is $2.46 M
What is the all time high annual accounts receivable for ReShape Lifesciences?
ReShape Lifesciences all-time high annual accounts receivable is $4.80 M
What is ReShape Lifesciences annual accounts receivable year-on-year change?
Over the past year, RSLS annual accounts receivable has changed by -$127.00 K (-4.90%)
What is ReShape Lifesciences quarterly accounts receivable?
The current quarterly accounts receivable of RSLS is $2.21 M
What is the all time high quarterly accounts receivable for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly accounts receivable is $5.01 M
What is ReShape Lifesciences quarterly accounts receivable year-on-year change?
Over the past year, RSLS quarterly accounts receivable has changed by -$802.00 K (-26.63%)